
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people wh... Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people who are suffering from fibromyalgia. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 3.875 | 3.875 | 3.875 | 0 | 0 | CS |
4 | 0 | 0 | 3.875 | 3.875 | 3.875 | 0 | 0 | CS |
12 | 0 | 0 | 3.875 | 3.875 | 3.875 | 0 | 0 | CS |
26 | -0.675 | -14.8351648352 | 4.55 | 5.705 | 3.15 | 444537 | 3.94655695 | CS |
52 | -5.125 | -56.9444444444 | 9 | 15.72 | 3.15 | 754436 | 5.66287257 | CS |
156 | -135.625 | -97.2222222222 | 139.5 | 227.7725 | 3.15 | 708311 | 16.75256801 | CS |
260 | -340.125 | -98.8735465116 | 344 | 359.75 | 3.15 | 542820 | 29.01959287 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions